Personalis logo

Personalis

PSNL | NASDAQ
Chart Builder DCF Calculator
$14.80
-$0.91 (-5.79%)
At close: Nov 16, 2026, 4:00 PM ET
$14.59
-$0.21 (-1.42%)
After-hours: Nov 16, 2026, 7:30 PM ET
-5.79%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
41
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #500/1021 (Top 49%)

Key Statistics

Market Data

Market Cap $1.6B
1D Range
14.79 15.69
52W Range
5.04 18.38

Valuation (TTM)

PE -12.65
PB 7.54
EV/EBITDA -13.26

Valuation (NTM)

Forward PE N/A
Forward PEG -0.72
Price Target $16.25
Loading financial charts...

Profile

Personalis, Inc. operates globally as a specialized cancer genomics firm. The company delivers advanced sequencing and data analysis capabilities, primarily supporting the development of novel cancer ...

Sector Healthcare
Employees 260
IPO Date Jun 20, 2019
Fiscal Year January - December

Latest News

PSNL Securities Notice: Personalis Shareholders are Notified to Contact BFA Law about its Investigation into the $16.25 per Share Take-Private Merger

5 days ago · globenewswire.com

PSNL Securities Notice: Personalis Shareholders are Notified to Contact BFA Law about its Investigation into the $16.25 per Share Take-Private Merger
PSNL Deal Alert: Personalis $16.25 per Share Merger Under Investigation – Contact BFA Law about the Pending Merger Investigation

8 days ago · globenewswire.com

PSNL Deal Alert: Personalis $16.25 per Share Merger Under Investigation – Contact BFA Law about the Pending Merger Investigation
PSNL Investigation Reminder: Personalis Shareholders Notified of Investigation into $16.25 per Share Merger – Contact BFA Law

11 days ago · globenewswire.com

PSNL Investigation Reminder: Personalis Shareholders Notified of Investigation into $16.25 per Share Merger – Contact BFA Law
PSNL Investigation Reminder: Personalis $16.25 per Share Merger Triggers Investigation on Behalf of Shareholders – Contact BFA Law if You Hold Shares

13 days ago · globenewswire.com

PSNL Investigation Reminder: Personalis $16.25 per Share Merger Triggers Investigation on Behalf of Shareholders – Contact BFA Law if You Hold Shares
PSNL Shareholder Notice: Personalis $16.25 per Share Merger Under Investigation on Behalf of Shareholders

14 days ago · prnewswire.com

PSNL Shareholder Notice: Personalis $16.25 per Share Merger Under Investigation on Behalf of Shareholders
PSNL Legal Notice: Personalis Shareholders are Notified to Contact BFA Law About the Ongoing Investigation into the $16.25 per Share Merger

15 days ago · businesswire.com

PSNL Legal Notice: Personalis Shareholders are Notified to Contact BFA Law About the Ongoing Investigation into the $16.25 per Share Merger
PSNL Investigation Reminder: Personalis' $16.25 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares

18 days ago · globenewswire.com

PSNL Investigation Reminder: Personalis' $16.25 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares
PSNL Merger Notice: BFA Law Notifies Personalis Shareholders of the Ongoing Investigation into the $16.25 per Share Merger

19 days ago · newsfilecorp.com

PSNL Merger Notice: BFA Law Notifies Personalis Shareholders of the Ongoing Investigation into the $16.25 per Share Merger
$PSNL Stock Market Alert: Personalis' $16.25 per Share Merger Is Under Investigation – Contact BFA Law if You Are a Shareholder

20 days ago · globenewswire.com

$PSNL Stock Market Alert: Personalis' $16.25 per Share Merger Is Under Investigation – Contact BFA Law if You Are a Shareholder
The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings

21 days ago · 247wallst.com

The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings

Earnings

Latest Earnings
Nov 4, 2026
EPS
-$0.32
Miss -21.52%
REV
$25.6M
Beat +18.82%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Hold
Price Target
$16.25
Upside
+9.80%
Buy (1)
Hold (4)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.